People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Biotech / Pharma, Other Technology, Other Energy, Consumer / Retail, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Greenlight Biosciences Inc. | — | Biotech / Pharma | Series D+ | $179.4M | $3.9B | 2017 |
| Provivi, Inc. | — | Other Technology | Series C | $130.9M | $2.7B | 2015 |
| Gevo, Inc. | — | Other Energy | Series B | $97.3M | $302.9M | 2009 |
| Consumer Physics, Inc. | — | Consumer / Retail | Series B | $45.1M | $3.8M | 2017 |
| Amfora Inc. | — | Other | Series A | $12.3M | $92.6M | 2017 |
| Abunda Corp | — | Other Health Care | Series A | $4.1M | $83.5M | 2009 |
| Impetus Agriculture, Inc. | — | Agtech / Foodtech | Pre-Seed | $915K | $11.4M | 2020 |
Ganesh Kishore at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ganesh Kishore on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Martha Schlicher | 2 | 4 |
| Frances Arnold | 2 | 2 |
| Samir Kaul | 1 | 32 |
| Mark Smith | 1 | 28 |
| Matthew Walker | 1 | 11 |
| Charles Bolten | 1 | 10 |
| Bruce Smith | 1 | 9 |
| Jonathan Fleming | 1 | 9 |
| Michael Liang | 1 | 9 |
| David Furneaux | 1 | 8 |
| Jason Dinges | 1 | 8 |
| G. Steven Burrill | 1 | 7 |
| Eric O'Brien | 1 | 6 |
| Andrey Zarur | 1 | 6 |
| William Rosenzweig | 1 | 5 |
| Roger Wyse | 1 | 5 |
| Neil Renninger | 1 | 4 |
| Brian Clevinger | 1 | 4 |
| Charles L. Cooney | 1 | 4 |
| Charles Cooney | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.